{"schema_version":"1","generated_at":"2026-11-18T21:42:12.867Z","data_as_of":null,"url":"https://www.findmykol.com/kol/hilary-hinshaw","json_url":"https://www.findmykol.com/kol/hilary-hinshaw/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"hilary-hinshaw","name":"Hilary Hinshaw","credential":"MD","specialty":"Gynecologic Oncology","specialty_raw":"Gynecologic Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"institution":"Indiana University Indianapolis","institution_url":"https://www.findmykol.com/institution/indiana-university-indianapolis","city":"Indianapolis","state":"IN","region":{"label":"Midwest","url":"https://www.findmykol.com/region/midwest"}},"identifiers":{"npi":"1811211519","openalex":"A5066553783"},"summary":"Hilary Hinshaw is an Oncology physician affiliated with Indiana University Indianapolis. OpenAlex indexes 11 publications with 430 citations (h-index 3).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":11,"cited_by_count":430,"h_index":3,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":10,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"Genmab U.S., Inc.","program_year":2025,"amount_usd":107.11,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811211519"},{"payer":"Eisai Inc.","program_year":2025,"amount_usd":91.41,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811211519"},{"payer":"Merck Sharp & Dohme LLC","program_year":2025,"amount_usd":47,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1811211519"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1811211519","source":"payments"},"prescribing":{"data_year":2024,"areas_total":4,"areas_shown":3,"areas":[{"area":"Metabolism & gastrointestinal","share_pct":37.6,"classes_total":1,"classes":[{"class":"Serotonin-3 Receptor Antagonist","setting":"prescribed","share_pct":37.6,"drugs":[{"name":"Ondansetron Odt","share_pct":60.4},{"name":"Ondansetron Hcl","share_pct":39.6}],"max_beneficiaries":null}]},{"area":"Cancer & immunology","share_pct":31.9,"classes_total":3,"classes":[{"class":"Aromatase Inhibitor","setting":"prescribed","share_pct":12.1,"drugs":[{"name":"Letrozole","share_pct":100}],"max_beneficiaries":null},{"class":"Kinase inhibitor","setting":"prescribed","share_pct":11.3,"drugs":[{"name":"Everolimus","share_pct":100}],"max_beneficiaries":null}]},{"area":"Nervous system","share_pct":22.7,"classes_total":1,"classes":[{"class":"Opioid Agonist","setting":"prescribed","share_pct":22.7,"drugs":[{"name":"Oxycodone-Acetaminophen","share_pct":100}],"max_beneficiaries":32}]}],"care_setting":{"dominant":"office","data_year":2024,"office_pct":67.6,"facility_pct":32.4},"source":"medicare"},"publications":{"total":11,"shown":5,"withheld":6,"matched_by":"OpenAlex author record","recent":[{"title":"Chemical inhibition of RPA gap protection sensitizes BRCA1-deficient cancers to PARP inhibition","year":2025,"journal":"bioRxiv (Cold Spring Harbor Laboratory)","source_url":"https://doi.org/10.1101/2025.04.09.647957","status":"verified"},{"title":"Effect of Quadratus Lumborum (QL) blocks on Post Anesthesia Care Unit (PACU) opioid usage in women undergoing Robotic-Assisted (RA) Hysterectomy (1179)","year":2023,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2023.06.099","status":"verified"},{"title":"A comparison of molecular tumor profiles from hispanic and non-hispanic women with ovarian cancer","year":2019,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2019.03.171","status":"verified"},{"title":"Is there a role for for minnelide in uterine serous cancers?","year":2019,"journal":"Gynecologic Oncology","source_url":"https://doi.org/10.1016/j.ygyno.2019.03.172","status":"verified"},{"title":"DNA repair targeted therapy: The past or future of cancer treatment?","year":2016,"journal":"Pharmacology & Therapeutics","source_url":"https://doi.org/10.1016/j.pharmthera.2016.02.003","status":"verified"}],"source":"works"},"contact":{"address_1":"8402 HARCOURT RD STE 420","city":"Indianapolis","state":"IN","zip":"462602053","phone":"317-415-6740","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1811211519","source":"identity"},"similar":[{"name":"Homer Twigg","slug":"homer-twigg","institution":"Indiana University Indianapolis","specialty":"Pulmonary Disease","url":"https://www.findmykol.com/kol/homer-twigg","json_url":"https://www.findmykol.com/kol/homer-twigg/profile.json"},{"name":"Thomas McAllister","slug":"thomas-mcallister","institution":"Indiana University Indianapolis","specialty":"Psychiatry","url":"https://www.findmykol.com/kol/thomas-mcallister","json_url":"https://www.findmykol.com/kol/thomas-mcallister/profile.json"},{"name":"Michael Econs","slug":"michael-econs","institution":"Indiana University Indianapolis","specialty":"Endocrinology, Diabetes & Metabolism","url":"https://www.findmykol.com/kol/michael-econs","json_url":"https://www.findmykol.com/kol/michael-econs/profile.json"},{"name":"Paula Trzepacz","slug":"paula-trzepacz","institution":"Indiana University Indianapolis","specialty":"Psychosomatic Medicine","url":"https://www.findmykol.com/kol/paula-trzepacz","json_url":"https://www.findmykol.com/kol/paula-trzepacz/profile.json"},{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Stuart Orkin","slug":"stuart-orkin","institution":"Harvard Medical School","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/stuart-orkin","json_url":"https://www.findmykol.com/kol/stuart-orkin/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":6}},"sources":{"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2022-06-29","provider_certified":"2022-06-29","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"},"medicare":{"name":"CMS Medicare Part D Prescribers and Part B","url":"https://data.cms.gov/provider-summary-by-type-of-service","provides":"Share of this prescriber's Medicare fee-for-service prescribing by drug class and therapeutic area, classified with WHO ATC and NLM RxClass","disclaimer":"Proportions of the prescriber's own classified prescribing, never patient counts or dollar amounts. Fee-for-service only; CMS publishes about 17 months after the fact and suppresses counts of ten patients or fewer.","data_year":2024}},"methodology_url":"https://www.findmykol.com/about#methodology"}